Biophytis SA Total Liabilities 2011-2026 | BPTS

Annual Total Liabilities Biophytis SA

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	20.4 M	25.2 M	14.9 M	4.76 M	3.87 M	1.85 M	1.52 M	1.04 M	1.08 M	-

All numbers in EUR currency

Indicator range from annual reports

Maximum	Minimum	Average
25.2 M	1.04 M	8.28 M

Total Liabilities of other stocks in the Biotechnology industry

Issuer	Total Liabilities	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	1.98 B	-	2.43 %	$ 254 M	Germany
Alterity Therapeutics Limited ATHE	5.89 M	$ 4.31	8.5 %	$ 10.4 B	Australia
Adverum Biotechnologies ADVM	109 M	-	-	$ 86.2 M	USA
Akouos AKUS	45.1 M	-	0.23 %	$ 488 M	USA
I-Mab IMAB	707 M	-	-	$ 866 M	China
AlloVir ALVR	42.9 M	-	4.14 %	$ 49.1 M	USA
Alexion Pharmaceuticals, Inc. ALXN	6.45 B	-	-	$ 40.3 B	USA
Genfit SA GNFT	215 M	-	2.54 %	$ 160 B	France
Akari Therapeutics, Plc AKTX	19.6 M	$ 5.52	7.71 %	$ 372 B	Britain
Aligos Therapeutics ALGS	35 M	$ 6.72	-12.27 %	$ 66.4 M	USA
Allakos ALLK	74.8 M	-	-	$ 28.6 M	USA
Alnylam Pharmaceuticals ALNY	4.18 B	$ 310.99	-2.86 %	$ 40.7 B	USA
EyeGate Pharmaceuticals, Inc. EYEG	8.16 M	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	6.77 M	-	-18.52 %	$ 27.3 M	Britain
Applied Molecular Transport AMTI	46.6 M	-	-	$ 10.1 M	USA
Amphastar Pharmaceuticals AMPH	840 M	$ 22.53	3.28 %	$ 1.05 B	USA
Applied Therapeutics APLT	72 M	-	-	$ 8.42 M	USA
BioNTech SE BNTX	2.76 B	$ 104.62	2.45 %	$ 27.2 B	Germany
Aptinyx APTX	28.4 M	-	-39.0 %	$ 4.57 M	USA
Aravive ARAV	51.5 M	-	-13.39 %	$ 1.45 M	USA
Институт стволовых клеток человека ISKJ	1.1 B	-	-	-	Russia
Advaxis ADXS	7.89 M	-	-9.65 %	$ 45.9 M	USA
Can-Fite BioPharma Ltd. CANF	3.45 M	$ 3.16	2.59 %	$ 5.2 M	Israel
Aeterna Zentaris AEZS	17.6 M	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	6.99 M	-	-10.17 %	$ 12.2 K	USA
BioXcel Therapeutics BTAI	140 M	$ 1.21	12.62 %	$ 14.8 M	USA
Aeglea BioTherapeutics AGLE	62.5 M	-	-	$ 1.01 B	USA
Akebia Therapeutics AKBA	344 M	$ 1.43	6.0 %	$ 368 M	USA
Ayala Pharmaceuticals AYLA	7.43 M	-	-	$ 7.46 M	Israel
Applied Genetic Technologies Corporation AGTC	37.2 M	-	-	$ 26.5 M	USA
Aquestive Therapeutics AQST	194 M	$ 4.37	2.46 %	$ 467 M	USA
AstraZeneca PLC AZN	65.4 B	-	-	$ 96.9 B	Britain
Arcutis Biotherapeutics ARQT	243 M	$ 24.54	1.45 %	$ 3.12 B	USA
Burford Capital Limited BUR	1.45 B	$ 4.89	4.82 %	$ 794 M	Britain
AIkido Pharma AIKI	43.5 M	-	1.93 %	$ 17.4 M	USA
Brainstorm Cell Therapeutics BCLI	11 M	-	-2.5 %	$ 5.88 M	USA
BioDelivery Sciences International BDSI	137 M	-	-4.8 %	$ 255 M	USA
Cabaletta Bio CABA	53 M	$ 3.35	-4.83 %	$ 337 M	USA
Celldex Therapeutics CLDX	55.8 M	$ 34.69	2.44 %	$ 2.3 B	USA
Autolus Therapeutics plc AUTL	411 M	$ 1.68	4.04 %	$ 447 M	Britain
Aptose Biosciences APTO	37.2 M	-	-45.71 %	$ 1.2 M	Canada
AVROBIO AVRO	6.35 M	-	1083.1 %	$ 745 M	USA
BeiGene, Ltd. BGNE	3.83 B	-	0.49 %	$ 251 B	Cayman-islands
bluebird bio BLUE	425 M	-	-	$ 546 M	USA
Akero Therapeutics AKRO	75.8 M	-	-	$ 3.67 B	USA
CureVac N.V. CVAC	470 M	-	-	$ 867 M	Germany
Cidara Therapeutics CDTX	51.5 M	-	-	$ 1.41 B	USA
CymaBay Therapeutics CBAY	142 M	-	-	$ 3.45 B	USA
Allena Pharmaceuticals ALNA	15.9 M	-	3.16 %	$ 1.9 M	USA